previously couple of years, the united kingdom has witnessed a revolution in clinical fat‑decline therapies — from your introduction of semaglutide (Wegovy®) to your escalating reputation of tirzepatide (Mounjaro®). Now, another name is drawing focus in equally clinical and public wellness circle